Does Risk Management Matter Anymore?
An article I published on LinkedIn the other day:
Or... Why Aren't MS Patients Worth It?
Recently, I was sent a genetic test that won much acclaim at ECTRIMS 2023. The test is simple, fast, and unequivocal.
Why is it important? As one of the 2.5 million plus Multiple Sclerosis (MS) patients in th...